Otivio AS, appoints Heal-Med Solutions as exclusive partner and distributor for FlowOx ™ and related products in Australia. 

Oslo, Norway / Sydney, Australia — Otivio AS, a Norwegian medical technology company dedicated to advancing non‑invasive therapies for circulatory disorders, today announced the appointment of  Heal-Med Solutions Pty Ltd as its new exclusive partner and distributor for FlowOx™ in Australia, effective 13 November 2025. 

FlowOx™ is an innovative, non‑invasive device designed to improve peripheral circulation through intermittent negative pressure therapy. The technology has gained strong clinical interest across Europe and the United States for its potential to support patients with peripheral arterial disease (PAD), diabetic foot complications, and other chronic circulatory challenges.

Strengthening access to Advanced Circulatory Therapy in Australia

​Heal-Med Solutions located in Sydney, brings deep expertise in advanced wound care, negative pressure therapy, and clinical innovation adoption. The company’s established relationships with clinicians, hospitals, and community care providers position it as a strong partner to introduce FlowOx™ to the Australian healthcare landscape. “We are delighted to welcome Heal-Med Solutions as our partner in Australia,” said Iacob Mathieson - Chief Scientific Officer and CEO, “Their clinical insight, market experience, and commitment to patient‑centered innovation make them an ideal distributor for FlowOx™. Together, we aim to expand access to a therapy that has the potential to meaningfully improve quality of life for patients living with chronic lower limb circulatory conditions.”

A Partnership built on clinical impact and Innovation

​Heal-Med Solutions will lead national distribution, clinical engagement, and market development activities for FlowOx™, including education, product support, and collaboration with key opinion leaders in vascular care, podiatry, and wound management.  “We are proud to partner with Otivio and distribute FlowOx™ in Australia,” said Milner Fernandes – Commercial Director for Heal-Med Solutions “There is a growing need for non‑invasive, home‑based solutions that support circulation and healing. FlowOx™ represents a meaningful step forward for patients and clinicians seeking proven evidence-based solutions to address lower-limb blood flow deficiencies and related conditions.”

About FlowOx™

FlowOx™ is a CE‑marked, non‑invasive medical device that uses intermittent negative pressure to stimulate blood flow in the lower limbs. Designed for home or clinical use, FlowOx™ supports patients with compromised circulation and has been the subject multiple clinical evaluations across Europe. FlowOx™ has an active Class IIa TGA registration in Australia.

​About Otivio AS

Otivio AS, a Norwegian medical‑technology company, is advancing non‑invasive circulation‑support solutions through its flagship device, FlowOx™. Used across Europe, the United Kingdom and North America, FlowOx™ applies intermittent negative pressure (INP) to create a controlled pressure environment around the lower limb. Clinical evaluations have reported improvements in microcirculation, skin temperature and patient comfort, supporting its use in individuals with chronic circulatory challenges. Designed for both home and clinical settings, FlowOx™ offers a simple, user‑friendly approach to supporting lower‑limb blood flow. Otivio AS continues to expand international access to FlowOx™ as part of its commitment to developing innovative, evidence‑informed technologies that enhance quality of life for people living with long‑term vascular conditions.

About Heal-Med Solutions

Heal‑Med Solutions Pty Ltd, a Sydney‑based healthcare company, has strengthened its position in the Australian market as a specialist provider of advanced wound‑care products and medical‑device technologies. The company represents leading global manufacturers and is the authorised Australian distributor of FlowOx™, a non‑invasive intermittent negative‑pressure device designed to support lower‑limb circulation. Heal‑Med Solutions delivers end‑to‑end commercial, regulatory and logistics capability, ensuring reliable supply, clear clinician engagement and high‑quality support across acute, community and primary care settings.​

​

​

​

​​